UK markets close in 8 hours 10 minutes

FibroGen, Inc. (0IL8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
49.36-3.33 (-6.31%)
As of 2:33PM GMT. Market open.
Full screen
Previous close52.69
Open50.53
Bid0.00 x N/A
Ask0.00 x N/A
Day's range49.36 - 50.53
52-week range49.36 - 50.53
Volume40
Avg. volumeN/A
Market cap3.489B
Beta (5Y monthly)1.36
PE ratio (TTM)N/A
EPS (TTM)-2.57
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Could The FibroGen, Inc. (NASDAQ:FGEN) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The FibroGen, Inc. (NASDAQ:FGEN) Ownership Structure Tell Us Something Useful?

    If you want to know who really controls FibroGen, Inc. ( NASDAQ:FGEN ), then you'll have to look at the makeup of its...

  • Who Has Been Buying FibroGen, Inc. (NASDAQ:FGEN) Shares?
    Simply Wall St.

    Who Has Been Buying FibroGen, Inc. (NASDAQ:FGEN) Shares?

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that...

  • Why FibroGen Got Mashed on Monday
    Motley Fool

    Why FibroGen Got Mashed on Monday

    On Monday, investors pushed down its stock price by 9%. The company announced that the Food and Drug Administration's (FDA) review of the company's new drug application (NDA) for roxadustat has been extended by three months. As the original action date was today, investors are coping with the one-two disappointment of FibroGen's failure to get a regulatory present in time for the holidays, and of roxadustat's inability to barrel into the new year as a marketable drug.